Andrew Dillon
Sir Andrew Dillon, (born 9 May 1954)[1] is the chief executive of the National Institute for Health and Care Excellence (NICE). He was general manager of the Royal Free Hospital and chief executive of St George's Healthcare NHS Trust. He joined NICE as its founding chief executive in 1999.
In September 2013 he wrote an open letter to The Times in which he said companies should be sure that all expenses spent on research were necessary in order justify the high prices demanded for new products assessed by health technology assessment (HTA) bodies such as NICE.
“If it really does cost £1.2bn to develop a new drug, the question the pharmaceutical industry must be able to answer is this: are you absolutely confident that it needs to?” [2]
He was said by the Health Service Journal to be the 34th most powerful person in the English NHS in December 2013.[3] and among The 25 most influential people in biopharma today.[4] As of 2015, Dillon was paid a salary of between £185,000 and £189,999 by NICE, making him one of the 328 most highly paid people in the British public sector at that time.[5]
Early life
Dillon was born in Sale, Cheshire. He attended St Ambrose College, Hale Barns, Cheshire, then North Cheshire College of Further Education and finally Manchester University.[6]
Personal life
Dillon is married to Alison Goodbrand and they have two daughters.[6]
References
- ↑ "Birthdays", The Guardian, p. 39, 9 May 2014
- ↑ "NICE questions cost of medicines development". PM Live. 6 September 2013. Retrieved 15 December 2013.
- ↑ "HSJ100 2013 The annual list of the most influential people in health". Health Service Journal. 11 December 2013. Retrieved 14 December 2013.
- ↑ "Sir Andrew Dillon – The 25 most influential people in biopharma today". Fierce Biotech. n.d. Retrieved 15 December 2013.
- ↑ "Senior officials 'high earners' salaries as at 30 September 2015 - GOV.UK". www.gov.uk. 2015-12-17. Retrieved 2016-03-13.
- 1 2 Bosely, Sarah (29 Aug 2008). "He listened carefully and didn't move a muscle". The Guardian Profile. The Guardian. Retrieved 9 May 2014.